Discontinuation report HIBERIX

Last updated on 2022-11-18 History
Report ID 175258
Drug Identification Number 02239200
Brand name HIBERIX
Common or Proper name Haemophilus influenzae type b (Hib) conjugate vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE
Strength(s) 10MCG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size All pack sizes / Tous les formats
ATC code J07AG
ATC description BACTERIAL VACCINES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2023-03-31
Actual discontinuation date
Remaining supply date 2023-06-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-11-18 French Compare
v1 2022-11-18 English Compare

Showing 1 to 2 of 2